Trademark: 88082170
Word
RELOYUS
Status
Registered
Status Code
700
Status Date
Tuesday, March 26, 2019
Serial Number
88082170
Registration Number
5709776
Registration Date
Tuesday, March 26, 2019
Mark Type
4000
Filing Date
Friday, August 17, 2018
Published for Opposition
Tuesday, January 8, 2019

Trademark Owner History
Celgene Corporation - Original Registrant

Classifications
5 Pharmaceutical preparations for use in the treatment of myelofibrosis, polycythemia vera, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Trademark Events
Mar 26, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Mar 26, 2019
Registered-Principal Register
Jan 8, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 8, 2019
Published For Opposition
Dec 19, 2018
Notification Of Notice Of Publication E-Mailed
Nov 30, 2018
Approved For Pub - Principal Register
Nov 30, 2018
Assigned To Examiner
Nov 28, 2018
Assigned To Lie
Nov 20, 2018
Teas Voluntary Amendment Received
Aug 25, 2018
New Application Office Supplied Data Entered
Aug 21, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24